IXA teams
The IXA workforce includes business developers, legal counsels, program managers, grant advisors and management staff. At nearly ten locations at the premises of the Amsterdam universities the teams deploy their expertise and large network to the benefit of researchers, students and external parties.
Select your team and meet the IXA experts of your university:
Team IXA AMC
Team IXA HvA
Pieter Wybenga
Advisor Research Funding FNWI-IvI & AHK/Business Developer HvAMaren Pannemann
Advisor Research Funding HvA FBE, FDMCI & KNAW HuC
Team IXA UvA
Pieter Wybenga
Advisor Research Funding FNWI-IvI & AHK/Business Developer HvASilvia Goddijn
Business Developer FGw, FEB, FMG, FdR & VL Humanities, LawHubAnnette Dirac
Advisor Research Funding FMG-PsyRes, CDE & FNWI-API, HIMS, SILSCarolien Zijderveld
Advisor Research Funding FGw-ASH & FNWI-IBED, IvIEls den Os
Advisor Research Funding FGw-AHM, ASCA, ARTES, ILLC & FdR & KNAW-NIODKarin van de Sande
Advisor Research Funding FNWI-ILLC, IoP, KdV, SILS
Team IXA VU-VUmc
Pieter van Bokhoven
Senior Business Development Manager - Industry Alliance Office of the Amsterdam NeuroscienceSasja Heetveld
Business Development Manager - Industry Alliance Office of the Amsterdam NeurosciencePrisca Leferink
Business Development Manager - Industry Alliance Office of the Amsterdam NeuroscienceMargot Muller
Business controller IXA & Business Manager Industry Alliance OfficeBarbara Goossens
Business Planning Manager - Industry Alliance Office of the Amsterdam NeuroscienceMaaike Leusden
Contract Manager - Industry Alliance Office of the Amsterdam Neuroscience
Intravacc to in-license CimCure’s iBoost technology, expanding its vaccine platform portfolio
CimCure, a spin-off of Amsterdam UMC and focusing on cancer immunotherapies for solid tumors, signed a strategic partnership agreement for in-licensing CimCure’s iBoost technology with Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing viral and bacterial vaccines. The iBoost (immune boost) technology was developed at Amsterdam […]
News
Alumni Joint Master Entrepreneurship (UvA/VU) often pursue entrepreneurial careers
An annual survey held by the program directors of the Joint Master Entrepreneurship (UvA/ VU), Bram Kuijken and Enno Masurel, has found that 17.8% of alumni have founded their own company and 11.0% are currently working freelance. Additionally, the study found that 41.9% of alumni is employed by a startup (19.7%) or a scale-up (22.2%). […]
News
2016 AMSIA winner receives CE Mark for non-radioactive tumor localization system
MedTech startup Sirius Medical has received CE Mark approval for Sirius Pintuition, a non-radioactive device to localize breast tumors. In 2016 Bram Schermers, then a scientist at NKI, pitched an early concept at the annual Amsterdam Science & Innovation Awards and won first prize! His pitch also caught the attention of seasoned entrepreneur Hubert Martens, […]
News